From your mouth to God's ears lax. I don't know what I would do but I would have to sell something.
Great problem to have huh? I would see what Berger does and evaluate the potential for the company at that time. Suddenly Pona is being talked about in the front line (something I have been asking over at BV forever), so we really don't know what it's potential is right now. 113 is a wild card, and could be their best drug (or a bust). We really don't know so let's see where it goes.
It could get very interesting around here in a few years, I would like to have something on the table to see what develops.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.